Bank of Montreal Can Buys 3,851 Shares of Huron Consulting Group Inc. (NASDAQ:HURN)

Bank of Montreal Can raised its stake in Huron Consulting Group Inc. (NASDAQ:HURN) by 121.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,014 shares of the business services provider’s stock after acquiring an additional 3,851 shares during the quarter. Bank of Montreal Can’s holdings in Huron Consulting Group were worth $694,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of HURN. Covestor Ltd boosted its position in Huron Consulting Group by 26,500.0% during the first quarter. Covestor Ltd now owns 266 shares of the business services provider’s stock worth $26,000 after purchasing an additional 265 shares during the period. Ashton Thomas Private Wealth LLC purchased a new position in Huron Consulting Group in the 2nd quarter valued at approximately $28,000. Daiwa Securities Group Inc. raised its holdings in Huron Consulting Group by 800.0% during the 1st quarter. Daiwa Securities Group Inc. now owns 1,800 shares of the business services provider’s stock valued at $174,000 after acquiring an additional 1,600 shares during the period. Dakota Wealth Management purchased a new stake in shares of Huron Consulting Group during the second quarter worth $219,000. Finally, PNC Financial Services Group Inc. boosted its holdings in shares of Huron Consulting Group by 39.5% in the fourth quarter. PNC Financial Services Group Inc. now owns 2,555 shares of the business services provider’s stock worth $263,000 after acquiring an additional 724 shares during the period. 93.90% of the stock is owned by institutional investors.

Insider Buying and Selling at Huron Consulting Group

In other news, CEO C. Mark Hussey sold 34,013 shares of the stock in a transaction on Friday, July 12th. The shares were sold at an average price of $100.69, for a total value of $3,424,768.97. Following the transaction, the chief executive officer now owns 85,081 shares of the company’s stock, valued at $8,566,805.89. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other news, CEO C. Mark Hussey sold 34,013 shares of the stock in a transaction dated Friday, July 12th. The stock was sold at an average price of $100.69, for a total transaction of $3,424,768.97. Following the transaction, the chief executive officer now directly owns 85,081 shares in the company, valued at approximately $8,566,805.89. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Kyle Featherstone sold 820 shares of the business’s stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $108.07, for a total value of $88,617.40. Following the completion of the sale, the insider now owns 1,565 shares of the company’s stock, valued at $169,129.55. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 45,181 shares of company stock worth $4,595,284 over the last three months. 2.02% of the stock is owned by insiders.

Analyst Ratings Changes

HURN has been the topic of a number of analyst reports. Barrington Research reiterated an “outperform” rating and set a $137.00 price objective on shares of Huron Consulting Group in a research note on Monday, September 9th. Benchmark reiterated a “buy” rating and set a $140.00 price target on shares of Huron Consulting Group in a research report on Wednesday, July 31st. Finally, StockNews.com upgraded shares of Huron Consulting Group from a “sell” rating to a “hold” rating in a research report on Saturday, August 3rd. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $131.75.

Huron Consulting Group Price Performance

NASDAQ:HURN opened at $106.03 on Wednesday. Huron Consulting Group Inc. has a 52-week low of $84.26 and a 52-week high of $115.65. The stock has a fifty day moving average of $106.76 and a 200 day moving average of $99.25. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.93 and a current ratio of 1.93. The firm has a market capitalization of $1.91 billion, a price-to-earnings ratio of 30.56 and a beta of 0.61.

Huron Consulting Group (NASDAQ:HURN) last issued its quarterly earnings results on Tuesday, July 30th. The business services provider reported $1.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.48 by $0.20. Huron Consulting Group had a return on equity of 20.44% and a net margin of 5.46%. The firm had revenue of $371.70 million during the quarter, compared to the consensus estimate of $374.33 million. During the same quarter last year, the company posted $1.38 EPS. The company’s revenue for the quarter was up 7.2% on a year-over-year basis. On average, research analysts expect that Huron Consulting Group Inc. will post 5.95 EPS for the current fiscal year.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.